Conclusions: These results suggest that an exercise (MIA and PRE) prescription for patients on HAART boosts their CD 4 count. Importantly, CD 4 count may be boosted more by MIA than by PRE exercises in patients on HAART and HAART-naive, respectively. The change factor suggests supports this conclusion and the effect size are of clinical significance. It exerts a substantial public health burden on cardiovascular health status and health care systems in India.
coSt-effectIveneSS Study of AntIhyPeRtenSIve dRugS In MuMbAI, IndIA
1 Recent studies have shown that the prevalence of hypertension is 25% in urban and 10% in rural people in India. 2 It exerts a substantial public health burden on cardiovascular health status and health care systems in India. 3 Antihypertensive treatment effectively reduces hypertension-related morbidity and mortality. 1 The cost of medications has always been a barrier to effective treatment. The increasing prevalence of hypertension requires use of costeffective treatment for the effective management of the disease. Objectives: The present study assesses the cost-effectiveness of antihypertensive drugs in patients with hypertension from Mumbai, India. Methods: A prospective cross-sectional study was conducted to assess the cost-effectiveness of antihypertensive drugs. Face-to-face interviews were conducted by using a validated questionnaire in a total of 136 (66 males, 70 females) patients with hypertension from F-North Ward, Mumbai, India. Cost-effectiveness was determined on the basis of a drug's cost, efficacy, adverse drug reactions, safety of administration, frequency of administration, and bioavailability. Results: Atenolol was most cost-effective (international normalized ratio [INR]: 5.5/unit of effectiveness), followed by the amlodipine + losartan combination (INR: 5.6/unit of effectiveness) and amlodipine (INR: 6.3/unit of effectiveness) in the present study. Thirty-eight (28%) patients received combination therapy. Lisinopril prescribed to16 (11.8%) patients was the least cost-effective drug (INR: 17.2/unit of effectiveness). Conclusions: Prescriptions of cost-effective antihypertensive drugs (73.5%) were more common than less cost-effective antihypertensive drugs (26.5%) in hypertensive patients from Mumbai, India. Most of the patients (72%) were prescribed monotherapy in the treatment of hypertension. Key words: antihypertensive, cost-effectiveness, hypertension, India. Disclosure of Interest: None declared. 1 India currently faces an uncertain future in relation to the potential burden that diabetes may impose on the country. An estimated US$ 2.2 billion would be needed to sufficiently treat all cases of type 2 diabetes mellitus (T2DM) in India. 2 Many interventions can reduce the burden of this disease. However, health care resources are limited; thus, interventions for diabetes treatment should be prioritized. Objectives: The present study assesses the cost-effectiveness of antidiabetic drugs in patients with T2DM from Mumbai, India. Methods: A prospective cross-sectional study was performed to assess the cost-effectiveness of antidiabetic drugs in patients with T2DM. Face-to-face interviews were conducted by using a validated questionnaire in a total of 152 (76 males, 76 females) patients with T2DM from F-North Ward, Mumbai, India. Cost-effectiveness was determined on the basis of a drug's cost, efficacy, adverse drug reactions, safety of administration, frequency of administration, and bioavailability. Results: The glimepiride plus pioglitazone combination was the most cost-effective (international normalized ratio [INR]: 3.7/unit of effectiveness), followed by glimepiride (INR: 6.6/unit of effectiveness) prescribed in nonobese patients with T2DM. Glimepiride plus metformin was the most cost-effective (INR: 5.9/unit of effectiveness) followed by metformin (INR: 6.7/unit of effectiveness) prescribed in
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